Myeloma

The U.S. Food and Drug Administration (FDA) has set a date for next year by which it will decide whether or not to approve a…

Some days, I watch my mother try to stand, and my breath catches. The doctors have warned us about bone weakness — how…

For seven years, I have kept up on developments in multiple myeloma research. I follow the latest treatments, the newest studies, and…

The U.S. Food and Drug Administration (FDA) has approved a new version of Sarclisa (isatuximab), an approved treatment for multiple myeloma sold by…

Regulatory authorities in two countries have given the green light for clinical testing of a novel treatment from Mabwell Bioscience — which the company…

I find myself watching my mother’s hands more often these days. It shouldn’t come as a surprise, though. After all, observation is one of…

A protein called IRF2 may help drive myeloma, and measuring its levels could help predict outcomes among people with the blood cancer, a new…

Some nights I sit beside my mum’s bed and look back on the four years since her myeloma diagnosis. I find it hard to…

U.S. authorities have granted a permanent billing code for Blenrep (belantamab mafodotin), an approved treatment for certain adults with hard-to-treat multiple myeloma., a…

A regulatory committee in the European Union has recommended expanding approval of a dual regimen for hard-to-treat myeloma —…